We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDO icon
76
Credo Technology Group
CRDO
$36.7B
$61M 0.32%
418,771
SPGI icon
77
S&P Global
SPGI
$128B
$60.7M 0.32%
124,659
+14,700
+13% +$7.87M
BNTX icon
78
BioNTech
BNTX
$23.3B
$58.1M 0.3%
589,452
+2,716
+0.5% +$290K
INSM icon
79
Insmed
INSM
$22.7B
$57.3M 0.3%
397,588
-41,100
-9% -$5.03M
QCOM icon
80
Qualcomm
QCOM
$177B
$56.7M 0.3%
340,908
-77,418
-19% -$12.3M
ROK icon
81
Rockwell Automation
ROK
$52.6B
$54.3M 0.28%
155,319
-41,753
-21% -$14.4M
EXC icon
82
Exelon
EXC
$49.1B
$53.9M 0.28%
1,198,043
-5,656
-0.5% -$248K
AWK icon
83
American Water Works
AWK
$27.1B
$53.7M 0.28%
385,819
-1,663
-0.4% -$235K
NEE icon
84
NextEra Energy
NEE
$189B
$52.3M 0.27%
692,169
+170,958
+33% +$12.5M
PFE icon
85
Pfizer
PFE
$144B
$51.8M 0.27%
2,033,302
-207,653
-9% -$5.13M
IQV icon
86
IQVIA
IQV
$40B
$51.8M 0.27%
272,747
+103,567
+61% +$18.8M
UTHR icon
87
United Therapeutics
UTHR
$26.2B
$51.7M 0.27%
123,387
+40,176
+48% +$13.5M
ZS icon
88
Zscaler
ZS
$24.6B
$51.2M 0.27%
170,808
+12,498
+8% +$3.56M
ORCL icon
89
Oracle
ORCL
$347B
$50.7M 0.27%
180,311
+24,948
+16% +$6.35M
TRV icon
90
Travelers Companies
TRV
$82.7B
$47.9M 0.25%
171,694
+151,504
+750% +$40.6M
SNPS icon
91
Synopsys
SNPS
$74.5B
$46.2M 0.24%
93,639
+4,221
+5% +$2.39M
COST icon
92
Costco
COST
$432B
$45.8M 0.24%
49,442
-3,424
-6% -$3.28M
EBAY icon
93
eBay
EBAY
$51.9B
$45.7M 0.24%
502,160
-178,687
-26% -$15.8M
MDB icon
94
MongoDB
MDB
$25B
$45.6M 0.24%
146,786
+35,730
+32% +$9.18M
USB icon
95
US Bancorp
USB
$99.8B
$44.9M 0.24%
928,888
+341,887
+58% +$16.2M
BAP icon
96
Credicorp
BAP
$31.1B
$44.8M 0.23%
168,390
+100,030
+146% +$24.7M
KO icon
97
Coca-Cola
KO
$383B
$44M 0.23%
663,396
-42,897
-6% -$2.95M
PH icon
98
Parker-Hannifin
PH
$126B
$43.7M 0.23%
57,624
-1,287
-2% -$950K
PEP icon
99
PepsiCo
PEP
$195B
$42.9M 0.22%
305,609
-8,848
-3% -$1.26M
SYF icon
100
Synchrony
SYF
$25B
$42.6M 0.22%
600,170
-64,836
-10% -$4.7M

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.